167 related articles for article (PubMed ID: 33033963)
1. Effect of different human tissue processing techniques on SARS-CoV-2 inactivation-review.
Paggiaro AO; Carvalho VF; Gemperli R
Cell Tissue Bank; 2021 Mar; 22(1):1-10. PubMed ID: 33033963
[TBL] [Abstract][Full Text] [Related]
2. Rapid and complete inactivation of SARS-CoV-2 by ultraviolet-C irradiation.
Storm N; McKay LGA; Downs SN; Johnson RI; Birru D; de Samber M; Willaert W; Cennini G; Griffiths A
Sci Rep; 2020 Dec; 10(1):22421. PubMed ID: 33380727
[TBL] [Abstract][Full Text] [Related]
3. Rapid SARS-CoV-2 Inactivation in a Simulated Hospital Room Using a Mobile and Autonomous Robot Emitting Ultraviolet-C Light.
Lorca-Oró C; Vila J; Pleguezuelos P; Vergara-Alert J; Rodon J; Majó N; López S; Segalés J; Saldaña-Buesa F; Visa-Boladeras M; Veà-Baró A; Campistol JM; Abad X
J Infect Dis; 2022 Feb; 225(4):587-592. PubMed ID: 34904659
[TBL] [Abstract][Full Text] [Related]
4. Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma.
Azhar EI; Hindawi SI; El-Kafrawy SA; Hassan AM; Tolah AM; Alandijany TA; Bajrai LH; Damanhouri GA
Vox Sang; 2021 Jul; 116(6):673-681. PubMed ID: 33277935
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light.
Gidari A; Sabbatini S; Bastianelli S; Pierucci S; Busti C; Bartolini D; Stabile AM; Monari C; Galli F; Rende M; Cruciani G; Francisci D
Viruses; 2021 Mar; 13(3):. PubMed ID: 33807521
[TBL] [Abstract][Full Text] [Related]
6. Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials.
Criscuolo E; Diotti RA; Ferrarese R; Alippi C; Viscardi G; Signorelli C; Mancini N; Clementi M; Clementi N
Emerg Microbes Infect; 2021 Dec; 10(1):206-210. PubMed ID: 33399524
[TBL] [Abstract][Full Text] [Related]
7. Disinfection of SARS-CoV-2 Contaminated Surfaces of Personal Items with UVC-LED Disinfection Boxes.
Bormann M; Alt M; Schipper L; van de Sand L; Otte M; Meister TL; Dittmer U; Witzke O; Steinmann E; Krawczyk A
Viruses; 2021 Mar; 13(4):. PubMed ID: 33807470
[TBL] [Abstract][Full Text] [Related]
8. Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads.
Pan Y; Long L; Zhang D; Yuan T; Cui S; Yang P; Wang Q; Ren S
Clin Chem; 2020 Jun; 66(6):794-801. PubMed ID: 32246822
[TBL] [Abstract][Full Text] [Related]
9. Risk of SARS-CoV-2 virus transmission from donor corneal tissue: A review.
Salz AK; Acharya M; Hofmann N; Wittmershaus I; Sangwan V; Börgel M; Mathur U
Indian J Ophthalmol; 2021 Jun; 69(6):1592-1597. PubMed ID: 34011748
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiation.
Ulloa S; Bravo C; Ramirez E; Fasce R; Fernandez J
J Virol Methods; 2021 Sep; 295():114216. PubMed ID: 34171342
[TBL] [Abstract][Full Text] [Related]
11. Effect of the Photocatalyst under Visible Light Irradiation in SARS-CoV-2 Stability on an Abiotic Surface.
Uema M; Yonemitsu K; Momose Y; Ishii Y; Tateda K; Inoue T; Asakura H
Biocontrol Sci; 2021; 26(2):119-125. PubMed ID: 34092715
[TBL] [Abstract][Full Text] [Related]
12. Effective
Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
[TBL] [Abstract][Full Text] [Related]
13. Simulated sunlight decreases the viability of SARS-CoV-2 in mucus.
Sloan A; Cutts T; Griffin BD; Kasloff S; Schiffman Z; Chan M; Audet J; Leung A; Kobasa D; Stein DR; Safronetz D; Poliquin G
PLoS One; 2021; 16(6):e0253068. PubMed ID: 34111204
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of SARS-CoV-2 inactivation using a deep ultraviolet light-emitting diode.
Minamikawa T; Koma T; Suzuki A; Mizuno T; Nagamatsu K; Arimochi H; Tsuchiya K; Matsuoka K; Yasui T; Yasutomo K; Nomaguchi M
Sci Rep; 2021 Mar; 11(1):5070. PubMed ID: 33658595
[TBL] [Abstract][Full Text] [Related]
15. Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure.
Loveday EK; Hain KS; Kochetkova I; Hedges JF; Robison A; Snyder DT; Brumfield SK; Young MJ; Jutila MA; Chang CB; Taylor MP
Viruses; 2021 Mar; 13(4):. PubMed ID: 33810401
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting stability and infectivity of SARS-CoV-2.
Chan KH; Sridhar S; Zhang RR; Chu H; Fung AY; Chan G; Chan JF; To KK; Hung IF; Cheng VC; Yuen KY
J Hosp Infect; 2020 Oct; 106(2):226-231. PubMed ID: 32652214
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products.
Darnell ME; Taylor DR
Transfusion; 2006 Oct; 46(10):1770-7. PubMed ID: 17002634
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives.
Welch SR; Davies KA; Buczkowski H; Hettiarachchi N; Green N; Arnold U; Jones M; Hannah MJ; Evans R; Burton C; Burton JE; Guiver M; Cane PA; Woodford N; Bruce CB; Roberts ADG; Killip MJ
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32839250
[TBL] [Abstract][Full Text] [Related]
19. Antiviral efficacy of personal care formulations against Severe Acute Respiratory Syndrome Coronavirus 2.
Mukherjee S; Vincent CK; Jayasekera HW; Yekhe AS
Infect Dis Health; 2021 Feb; 26(1):63-66. PubMed ID: 33012695
[TBL] [Abstract][Full Text] [Related]
20. Assessment of inactivation procedures for SARS-CoV-2.
Auerswald H; Yann S; Dul S; In S; Dussart P; Martin NJ; Karlsson EA; Garcia-Rivera JA
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
